Actively Recruiting
Study of Patient With Frequent Exacerbations in Moscow
Led by AstraZeneca · Updated on 2026-04-20
500
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This Study is multicenter, non-interventional, ambispective registry to evaluate the demographic and clinical characteristics, therapeutic approaches and outcomes in COPD outpatients with frequent exacerbations in Moscow
CONDITIONS
Official Title
Study of Patient With Frequent Exacerbations in Moscow
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older at the time of inclusion
- Signed and dated written informed consent before joining the study
- Confirmed diagnosis of moderate-to-very severe (GOLD 2-4) COPD with a post-bronchodilator FEV1/FVC ratio less than 0.7
- At least 2 moderate or 1 severe COPD exacerbations in the previous 52 weeks
- Using dual inhaled maintenance therapy (LABA/LAMA, ICS/LAMA, or ICS/LABA) for at least 6 weeks before screening
You will not qualify if you...
- Current or previous treatment with triple combination (ICS/LAMA/LABA) maintenance therapy within 52 weeks before screening
- COPD caused by documented alpha-1-antitrypsin deficiency
- Diagnosis of bronchiectasis, sarcoidosis, interstitial lung diseases, idiopathic pulmonary fibrosis, asthma exacerbation, or other acute/chronic diseases limiting participation or affecting results
- Participation in any interventional clinical study currently or within 52 weeks before inclusion; participation in non-interventional observational registries without treatment changes is allowed
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Research Site
Moscow, Russia
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here